Sai Parenteral's

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H9F01037
  • NSEID: SAIPARENT
  • BSEID: 544742
INR
486.05
-0.9 (-0.18%)
BSENSE

Apr 30

BSE+NSE Vol: 70.87 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

70.87 k (-55.13%) Volume

Shareholding (Apr 2026)

FII

5.73%

Held by 9 FIIs

DII

6.16%

Held by 6 DIIs

Promoter

51.16%

Why is Sai Parenterals Ltd falling/rising?

30-Apr-2026

As of 29-Apr, Sai Parenterals Ltd's stock price is rising to 485.80, supported by positive trends above key moving averages. However, a 19.11% decline in delivery volume raises concerns about future performance despite the stock's liquidity.

As of 29-Apr, Sai Parenterals Ltd's stock price is rising, currently at 485.80, with a change of 1.85 (0.38%) upward. This increase is supported by the fact that the stock is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price performance. Additionally, the stock's performance today is described as inline with the sector, suggesting that it is maintaining a stable position relative to its peers. <BR><BR>However, it is important to note that there has been a decline in investor participation, with delivery volume on 28 April falling by 19.11% compared to the 5-day average. Despite this drop in participation, the stock remains liquid enough for trading, as indicated by its liquidity based on 2% of the 5-day average traded value. Overall, while the stock is experiencing a rise in price, the decrease in delivery volume may be a point of concern for future performance.

View full answer

Which are the latest news on Sai Parenteral's?

30-Apr-2026
No latest news for Sai Parenteral's found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 2,156 Cr (Small Cap)

stock-summary
P/E

206.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.77

stock-summary
Return on Equity

11.32%

stock-summary
Price to Book

23.51

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
28.14%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.59%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
206
Industry P/E
33
Price to Book Value
23.36
EV to EBIT
102.73
EV to EBITDA
81.80
EV to Capital Employed
13.61
EV to Sales
17.74
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.24%
ROE (Latest)
11.32%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (3.81%)

FIIs

Held by 9 FIIs (5.73%)

Promoter with highest holding

Vijitha Gorrepati (28.91%)

Highest Public shareholder

Quant Mutual Fund - Quant Small Cap Fund (3.81%)

Individual Investors Holdings

22.67%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Sai Parenteral's"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Sai Parenteral's"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Sai Parenteral's"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "124.27",
          "val2": "113.89",
          "chgp": "9.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.95",
          "val2": "21.47",
          "chgp": "25.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.31",
          "val2": "6.17",
          "chgp": "18.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.34",
          "val2": "7.16",
          "chgp": "44.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "21.69%",
          "val2": "18.85%",
          "chgp": "2.84%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
124.27
113.89
9.11%
Operating Profit (PBDIT) excl Other Income
26.95
21.47
25.52%
Interest
7.31
6.17
18.48%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.34
7.16
44.41%
Operating Profit Margin (Excl OI)
21.69%
18.85%
2.84%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Sai Parenterals Ltd stock-summary
stock-summary
Sai Parenterals Ltd
Small Cap
Pharmaceuticals & Biotechnology
Sai Parenteral's Limited was originally incorporated as `Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to `Sai Parenteral's Limited' w.e.f January 17, 2022.
Company Coordinates stock-summary
Icon
No Company Details Available